Market: Zydus goes global with CDMO
2 Articles
2 Articles
Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market - Express Pharma
Zydus Lifesciences has announced its planned entry into the global biologics contract development and manufacturing organisation (CDMO) sector through the acquisition of Agenus Inc.’s biologics manufacturing facilities in California, United States. This acquisition provides Zydus with access to biologics development and manufacturing capabilities, including pre-clinical development and large-scale commercial production. The facilities are staffe…
Market: Zydus goes global with CDMO
Patel strengthens US foothold with Agenus acquisition Zydus Lifesciences Ltd of Ahmedabad has announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to acquire Agenus Inc.’s (Nasdaq: AGEN) US-based biologics CMC facilities. This acquisition marks Zydus’ strategic investment in US-based manufacturing for biologics thereby adding a sustainable […] Source
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage